Format

Send to

Choose Destination
Arch Neurol. 2009 Jul;66(7):821-8. doi: 10.1001/archneurol.2009.104.

Emerging therapies for relapsing multiple sclerosis.

Author information

1
Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, Ohio 44195, USA. cohenj@ccf.org

Abstract

Six agents are currently approved by regulatory agencies to treat relapsing multiple sclerosis. Although these agents are effective and generally safe, some patients have continued disease activity or adverse effects. A sizable number of new agents are under investigation currently. This article reviews emerging agents that have shown promise in phase 2 trials.

PMID:
19597083
DOI:
10.1001/archneurol.2009.104
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center